Surrozen receives FDA clearance for SZN-8141 IND application
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
More in Health & Medicine
Gender Ministry launches breast cancer awareness campaign in Ho
The Minister for Gender, Children and Social Protection, Dr Agnes Naa Momo Lartey, has launched the 2026 Breast Cancer Screening and Awareness Campaign in Ho, Volta Region, with a call for greater…
Teva Presents New Efficacy and Safety Data with Ecopipam, an Investigational Treatment for Pediatric Patients with Tourette Syndrome
Based on a post hoc analysis, a majority of participants (~70%) experienced clinically meaningful tic reduction within 8 weeks of starting ecopipam An interim 18-month analysis of an ongoing…
Journal of Child Neurology Publishes Review Highlighting Dopamine’s Role in Tourette Syndrome and Ecopipam’s Selective D1 Receptor Mechanism for Tourette Syndrome in Pediatric Patients
The published review examines dopamine’s role in tic generation and how approved and investigational drugs may affect dopamine to reduce tics as well as synthesizes clinical trial evidence that…
An Ebola treatment center was burned down as the death toll in Congo passes 4,000
Congo's Ebola outbreak has recorded more than 4,000 deaths, authorities said, as they struggle to contain the spread of the virus.
Denmark’s Breye Therapeutics raises €67.5 million to advance oral therapies for early treatment of retinal diseases
Breye Therapeutics (Breye), a Danish clinical-stage biopharmaceutical company developing oral therapeutics for the early treatment of retinal diseases, has closed an oversubscribed €67.5 million…